Users particularly appreciated the ability to engage in the two-way communication necessary for health guidance using contact methods tailored to each individual, such as email, LINE,* and SMS, as well as the error-checking function that streamlines claims and billing processes with insurers.

* LINE is a registered trademark of LY Corporation.

Because physicians operate Teladoc HEALTH remotely, the burden on on-site staff is minimal. By connecting the system to peripheral medical devices, healthcare professionals can assess a patient’s condition with the same speed and sense of presence as if they were there in person. The system has been well received as a means of improving regional access to routine and specialty healthcare, maintaining quality of care, and supporting sustainable working practices for healthcare professionals.

Healthcare professionals see value in different approaches for different patients, but we consistently hear appreciation for the accuracy, simplicity, and ease of use of CONTOUR^® systems. For women with gestational diabetes, accuracy is especially important in supporting treatment decisions for both mother and baby, while features such as the smartLIGHT indicator and Second-Chance^® sampling are designed with the practical needs of people managing diabetes in mind.

READsystem^® is a comprehensive diagnostic system for malignant lymphoma for which LSI Medience provides testing services. Malignant lymphoma is generally regarded as a challenging disease to diagnose, requiring a comprehensive assessment based not only on clinical information but also on a variety of diagnostic data, including cytogenetic and genetic analyses. READsystem^® enables accurate and rapid diagnosis by simultaneously performing the necessary tests and integrating the findings through a comprehensive evaluation by highly experienced pathologists with the results of relevant diagnostic testing. The system has been adopted by numerous medical institutions throughout Japan and provides information that enhances physicians’ diagnostic efficiency and supports patients in selecting the most appropriate treatment options.

PATHFAST, which enables rapid testing using whole blood, has been praised in emergency settings for shortening turnaround time for test results. It supports rapid diagnostic decision-making and earlier patient care.

In cancer diagnostics, the final step in the digital pathology workflow is image acquisition. Epredia’s E1000 Dx Digital Pathology Solution, introduced in 2024, combines high-throughput scanning with advanced workflow management to help laboratories accelerate their transition from traditional microscopy to digital diagnosis. Together, SuperFrost™ Plus slides, SlideMate Laser technology, and the E1000 platform demonstrate how Epredia’s precision technologies work seamlessly across the pathology workflow—from specimen preparation to digital image analysis—helping pathologists deliver faster, more accurate cancer diagnoses.

Medicom Cloud EMR includes extensive medical-receipt checking functions and an AI-powered automated billing support function that identifies billable items from information entered in the medical record. Leveraging more than 50 years of experience in developing medical-receipt computers, this proprietary reimbursement support feature helps clinics operate and manage their practices more efficiently.

We are currently involved in pharmaceutical regulatory applications for many vaccines developed by Japanese manufacturers. We recently established a biosafety level 3 (BSL-3) facility, one of the few in Japan capable of supporting pharmaceutical regulatory submissions. Previously, obtaining the data required for regulatory submissions related to the development of vaccines and therapeutic drugs in preparation for pandemics and other public health emergencies required reliance on facilities outside Japan, but we can now conduct this work in-country.

These ultra-low temperature freezers maintain temperatures in the -80°C range. Their dual-cooling systems use two independent refrigeration circuits and non-HFC refrigerants, maintaining an internal temperature of -75°C even if one circuit fails. This reduces the risk of sample loss and improves energy efficiency.

The unit precisely controls the optimal temperature, CO₂, and humidity for cell culture. A proprietary active humidification system maintains stable humidity and achieves rapid recovery after the door is opened and closed. This reduces the risk of culture medium dehydration and condensation, enabling researchers to achieve a culturing environment with a high degree of reproducibility.

In cancer diagnostics, even the most advanced technologies depend on a simple starting point: the microscope slide. For almost 30 years, Epredia’s SuperFrost™ Plus slides have been the gold standard within the industry. Strong tissue adhesion is especially important in modern techniques such as H&E, special stains, and immunohistochemistry (IHC). Maintaining specimen integrity helps laboratories deliver reliable and consistent diagnostic results with the patients in mind.

LiCellMo™ allows researchers to visualize changes in cellular metabolism in real time. High-precision In-Line sensors measure glucose and lactate, enabling users to understand and evaluate the metabolic state of cells. This supports the acquisition of metabolic data in fields such as cancer immunotherapy, including CAR-T therapy, stem cell research, and process development.

Continuous measurement using In-Line sensors enables visualization of changes in glucose and lactate concentrations. Automated culture control maintains the optimal culture environment, contributing to improved cell quality and greater process stability in manufacturing of cell therapies including CAR-T therapy.